Efficacy and safety of imiquimod in the treatment of subclinicaland clinical forms of persistent cervical papillomavirus infection in patients of early reproductive age

• Egile Nagusiak: N I Tapilskaya (Egilea), I N Vorobtsova (Egilea), S N Gaidukov (Egilea), S N Proshin (Egilea)
• Formatua: Liburua
• Argitaratua: IP Berlin A.V., 2015-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Objectives. HPV infection is a major risk factor for cervix cancer. This study evaluated cervical application of imiquimodfortreatment of subclinical (flat condyloma) and clinical (CIN I, LSIL) manifestations of human papillomavirus infection. Methods. An open controlled study (n=28) efficacy and sa...